Literature DB >> 18159449

Legionnaires' disease - Results of a multicentre Canadian study.

Thomas J Marrie1, Emidio De Carolis, Victor L Yu, Janet Stout.   

Abstract

BACKGROUND: There has never been a cross-Canada surveillance project to determine the rate of Legionella species as a cause of community-acquired pneumonia requiring hospitalization and to determine whether there are any regional differences in the rates of Legionnaires' disease in Canada. Anecdotally, Legionnaires' disease is thought to be uncommon in Western Canada.
METHODS: From January, 1996 through to October 31, 1997, a prospective study of the etiology of community acquired pneumonia requiring admission to 15 tertiary care hospitals in eight Canadian provinces was conducted. A urine sample from each patient was tested for Legionella pneumophila serogroup 1 antigen using a commercially available ELISA assay. A culture of sputum or other respiratory specimens for Legionellaceae was carried out at the discretion of the attending physician. Two hundred thirty-four patients had acute and 6-week convalescent serum samples tested for antibodies to L pneumophila serogroups 1 through 6 using an ELISA method.
RESULTS: 28 of the 850 patients (3.2%) had Legionnaires' disease; 18 of 823 (2.1%) were positive for L pneumophila serogroup 1 by urinary antigen testing. The rate of Legionnaires' disease, based on urinary antigen, at the Halifax site was higher than that at the other sites (seven of 163 patients versus 11 of 660 [P=0.04]). Of the 28 cases of Legionnaires' disease identified using all methods, 11 of 277 patients (3.9%) were enrolled from Western provinces versus 17 of 573 patients (2.9%) from Eastern provinces (P=nonsignificant).
CONCLUSIONS: Legionnaires' disease is just as common in Western as in Eastern Canada. L pneumophila serogroup 1 may be more common in Halifax than at the other sites studied.

Entities:  

Keywords:  Acquired pneumonia; Canada; Legionella; Legionella urine antigen; Legionnaires' disease

Year:  2003        PMID: 18159449      PMCID: PMC2094927          DOI: 10.1155/2003/951567

Source DB:  PubMed          Journal:  Can J Infect Dis        ISSN: 1180-2332


  29 in total

Review 1.  The treatment of Legionnaires' disease.

Authors:  M Dedicoat; P Venkatesan
Journal:  J Antimicrob Chemother       Date:  1999-06       Impact factor: 5.790

2.  Antimicrobial chemotherapy for Legionnaires disease: time for a change.

Authors:  P H Edelstein
Journal:  Ann Intern Med       Date:  1998-08-15       Impact factor: 25.391

3.  Comparative study of the clinical presentation of Legionella pneumonia and other community-acquired pneumonias.

Authors:  N Sopena; M Sabrià-Leal; M L Pedro-Botet; E Padilla; J Dominguez; J Morera; P Tudela
Journal:  Chest       Date:  1998-05       Impact factor: 9.410

4.  Seroepidemiology of Q fever in Nova Scotia and Prince Edward Island.

Authors:  T J Marrie; J Van Buren; R S Faulkner; E V Haldane; J C Williams; C Kwan
Journal:  Can J Microbiol       Date:  1984-01       Impact factor: 2.419

5.  Ecological distribution of Legionellaceae in the Quebec city area.

Authors:  J R Joly; M Boissinot; J Duchaine; M Duval; J Rafrafi; D Ramsay; R Letarte
Journal:  Can J Microbiol       Date:  1984-01       Impact factor: 2.419

6.  Measurement of antibody responses to pneumolysin--a promising method for the presumptive aetiological diagnosis of pneumococcal pneumonia.

Authors:  E Jalonen; J C Paton; M Koskela; Y Kerttula; M Leinonen
Journal:  J Infect       Date:  1989-09       Impact factor: 6.072

7.  Fatal Legionella maceachernii pneumonia in Canada.

Authors:  E Thomas; N K Gupta; N G van der Westhuizen; E Chan; K Bernard
Journal:  J Clin Microbiol       Date:  1992-06       Impact factor: 5.948

8.  Community-acquired pneumonia: impact of immune status.

Authors:  L M Mundy; P G Auwaerter; D Oldach; M L Warner; A Burton; E Vance; C A Gaydos; J M Joseph; R Gopalan; R D Moore
Journal:  Am J Respir Crit Care Med       Date:  1995-10       Impact factor: 21.405

9.  Detection of Legionella pneumonophila antigen in urine by enzyme-linked immunospecific assay.

Authors:  B P Berdal; C E Farshy; J C Feeley
Journal:  J Clin Microbiol       Date:  1979-05       Impact factor: 5.948

10.  Legionellaceae in the potable water of Nova Scotia hospitals and Halifax residences.

Authors:  T Marrie; P Green; S Burbridge; G Bezanson; S Neale; P S Hoffman; D Haldane
Journal:  Epidemiol Infect       Date:  1994-02       Impact factor: 2.451

View more
  5 in total

1.  Legionellosis: Why should I test and report?

Authors:  Thomas J Marrie; Jason R Garay; Erica Weir
Journal:  CMAJ       Date:  2010-07-05       Impact factor: 8.262

2.  Legionella pneumophila monoclonal antibody subgroups and DNA sequence types isolated in Canada between 1981 and 2009: Laboratory Component of National Surveillance.

Authors:  A R Reimer; S Au; S Schindle; K A Bernard
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-12-04       Impact factor: 3.267

Review 3.  Global Perspective of Legionella Infection in Community-Acquired Pneumonia: A Systematic Review and Meta-Analysis of Observational Studies.

Authors:  Frances F Graham; Norah Finn; Paul White; Simon Hales; Michael G Baker
Journal:  Int J Environ Res Public Health       Date:  2022-02-08       Impact factor: 3.390

4.  Laboratory-based evaluation of legionellosis epidemiology in Ontario, Canada, 1978 to 2006.

Authors:  Victoria Ng; Patrick Tang; Frances Jamieson; Cyril Guyard; Donald E Low; David N Fisman
Journal:  BMC Infect Dis       Date:  2009-05-21       Impact factor: 3.090

5.  Legionnaires' Disease Cases at a Large Community Hospital-Common and Underdiagnosed.

Authors:  Jamie Spiegelman; Theresa Pedutem; Mary June Francisco
Journal:  Int J Environ Res Public Health       Date:  2020-01-03       Impact factor: 3.390

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.